心力衰竭入院后缺血性左心室功能障碍的重血管化和结果:RevascHeart研究
Carlos Moliner-Abós1, Maria Calvo-Barceló2, Eduard Solé-Gonzalez3
1Cardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
European journal of heart failure
|October 3, 2024
概括
与指导方针导向的医疗治疗相比,重血管化并没有改善心力衰竭患者的长期存活率,这些患者患有缺血左心室功能障碍. 需要进一步的前性研究来证实这些发现.
科学领域:
- 心脏病学 心脏病学
- 心血管研究研究心血管研究
- 心脏衰竭管理的管理
背景情况:
- 在缺血性左心室 (LV) 功能障碍的心力衰竭 (HF) 中,重血管化的作用仍在争论中.
- 指南导向医学疗法 (GDMT) 在HF结局方面已经证明有好处.
研究的目的:
- 为了比较复血管化和GDMT之间的长期死亡率,在患有缺血性LV功能障碍的患者中,在HF入院后.
- 评估复血管化策略 (PCI与CABG) 对死亡率和LV重塑的影响.
主要方法:
- 一个多中心的回顾性分析包括408名患有HF,LVEF≤40%和冠状动脉疾病 (CAD) 的患者.
- 患者接受了再血管化 (PCI或CABG) 或GDMT治疗.
- 主要结局是全因或心血管死亡率;次要结局包括LV反向重塑.
主要成果:
- 经过44.6个月的中位随访后,与GDMT (43%的死亡率) 相比,再血管 (33%的死亡率) 并没有显著降低全因或心血管死亡率.
- 穿皮冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG) 都没有显示出与GDMT相比的死亡率好处.
- 两组都显示LV反向重塑,在重血管化组观察到的改善更大.
结论:
- 在接受高血压后患有缺血性LV功能障碍的患者中,重血管化没有显示出高于GDMT的长期死亡率优势.
- 需要进行更大规模的前性研究,以确定重新血管化的作用在这种患者群体中.
相关概念视频
01:29Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
01:22Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
01:30Heart Failure IV: Classification and Diagnostic Evaluation
2
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2